HLA-DRB1 and myeloid sarcoma: There are differences in EBNA‐1 IgG levels monthly, an association between EBNA‐1 IgG, 25(OH)D levels, and HLA‐DRB1*15; therefore, EBNA‐1 IgG serum levels are influenced by genetic and environmental factors that impact the risk of MS.